Cargando…
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China
BACKGROUND: We aimed to establish a Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS) in China and evaluate the completeness and timeliness of this system through reporting cancer incidence rates using claims data in two regions in northern and southern China. METHODS: We extracte...
Autores principales: | Tian, Hongrui, Yang, Wei, Hu, Yanjun, Liu, Zhen, Chen, Lei, Lei, Liang, Zhang, Fan, Cai, Fen, Xu, Huawen, Liu, Mengfei, Guo, Chuanhai, Chen, Yun, Xiao, Ping, Chen, Junhui, Ji, Ping, Fang, Zhengyu, Liu, Fangfang, Liu, Ying, Pan, Yaqi, dos-Santos-Silva, Isabel, He, Zhonghu, Ke, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090368/ https://www.ncbi.nlm.nih.gov/pubmed/32215367 http://dx.doi.org/10.1016/j.eclinm.2020.100312 |
Ejemplares similares
-
Identification of cancer patients using claims data from health insurance systems: A real-world comparative study
por: Tian, Hongrui, et al.
Publicado: (2019) -
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China
por: Tian, Hongrui, et al.
Publicado: (2021) -
The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017)
por: Tian, Hongrui, et al.
Publicado: (2021) -
Health-seeking behavior and barriers to treatment of patients with upper gastrointestinal cancer detected by screening in rural China: real-world evidence from the ESECC trial
por: Wang, Hui, et al.
Publicado: (2021) -
Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons From the ESECC Trial
por: Li, Fuxiao, et al.
Publicado: (2022)